Previous studies have linked elevated SCARB2 to tumor progression in breast cancer (Zhao et al., 2025) and liver cancer (Wang et al., 2023), where it regulates key pathways, such as MYC acetylation and tumor-infiltrating immune cell levels. This evidence concerns the gene SCARB2 and liver cancer.